Novel PANK2 gene mutations in Korean patient with pantothenate kinase-associated neurodegeneration presenting unilateral dystonic tremor

Movement Disorders

Volumn 25, Issue 2, 2010, Pages 245-247

  Yoon, Won Tae ^a   Lee, Won Yong ^a   Shin, Hee Young ^a   Lee, Seung Tae ^a   Ki, Chang Seok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEVODOPA; MUSCLE RELAXANT AGENT; PANTOTHENATE KINASE 2;

ADD ON THERAPY; ADULT; ARM MOVEMENT; CASE REPORT; CERVICAL SPINE; FAMILY HISTORY; GAIT; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HAND MOVEMENT; HUMAN; KOREA; LETTER; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PHENOTYPE; POPULATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; UNILATERAL DYSTONIC TREMOR;

ARM; DYSTONIC DISORDERS; HAND; HUMANS; KOREA; MALE; MIDDLE AGED; MUTATION; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TREMOR;

EID: 77649108633     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22891     Document Type: Letter

References (8)

1. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat genet 2001;28:345-349.
2. Hartig MB, Hortnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neuro-degeneration with brain iron accumulation. Ann Neurol 2006;59: 248-256.
3. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33-40.
4. Pellecchia MT, Valente EM, Cif L, et al. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology 2005;64:1810-1812.
5. Wu YR, Chen CM, Chao CY, Lyu RK, Lee-Chen GJ. Pantothenate kinase-associated neurodegeneration in two Taiwanese siblings: identification of a novel PANK2 gene mutation. Mov Disord 2009;24:940-941.
6. Yamashita S, Maeda Y, Ohmori H, et al. Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene. J Neurol Sci 2004;225:129-133.
7. Antonini A, Goldwurm S, Benti R, et al. Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration. Mov Disord 2006;21:417-418.
8. Chung SJ, Lee JH, Lee MC, Yoo HW, Kim GH. Focal hand dystonia in a patient with PANK2 mutation. Mov Disord 2008;23: 466-468.